Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

AAPL Practice Resource for the Forensic Evaluation of Psychiatric Disability.

Anfang SA, Gold LH, Meyer DJ.

J Am Acad Psychiatry Law. 2018 Mar;46(1 Supplement):S2-S47. No abstract available.

PMID:
29752290
2.

AAPL Practice Resource for the Forensic Evaluation of Psychiatric Disability.

Anfang SA, Gold LH, Meyer DJ.

J Am Acad Psychiatry Law. 2018 Mar;46(1):102.

PMID:
29618542
3.

American Psychiatric Association: Position Statement on Firearm Access, Acts of Violence and the Relationship to Mental Illness and Mental Health Services.

Pinals DA, Appelbaum PS, Bonnie R, Fisher CE, Gold LH, Lee LW.

Behav Sci Law. 2015 Jun;33(2-3):195-8. doi: 10.1002/bsl.2180.

PMID:
26095100
4.

Resource Document on Access to Firearms by People with Mental Disorders.

Pinals DA, Appelbaum PS, Bonnie RJ, Fisher CE, Gold LH, Lee LW.

Behav Sci Law. 2015 Jun;33(2-3):186-94. doi: 10.1002/bsl.2181.

PMID:
26095099
5.
6.

Introduction to the special section on DSM-5 and forensic psychiatry.

Wills CD, Gold LH.

J Am Acad Psychiatry Law. 2014;42(2):132-5. No abstract available.

PMID:
24986338
7.

Gun violence: psychiatry, risk assessment, and social policy.

Gold LH.

J Am Acad Psychiatry Law. 2013;41(3):337-43. No abstract available.

PMID:
24051585
8.

Commentary: Challenges in providing psychiatric disability evaluations.

Gold LH.

J Am Acad Psychiatry Law. 2011;39(2):189-93.

PMID:
21653262
9.

Personal accounts: the psychiatrist-mom: added stigmatization when children have ADHD.

Gold LH.

Psychiatr Serv. 2010 Dec;61(12):1181-2. doi: 10.1176/ps.2010.61.12.1181. No abstract available.

PMID:
21123400
10.

Comment on: POWs versus torturers: forensic evaluation of military personnel.

Levin AP, Gold LH.

J Am Acad Psychiatry Law. 2010;38(1):145-6. No abstract available.

PMID:
20305086
11.

POWs versus torturers: forensic evaluation of military personnel.

Levin AP, Gold LH, Onorato AA.

J Am Acad Psychiatry Law. 2009;37(3):316-28.

PMID:
19767496
12.

Synthesis and SAR of tolylamine 5-HT6 antagonists.

Singer JM, Wilson MW, Johnson PD, Graham SR, Cooke LW, Roof RL, Boxer PA, Gold LH, Meltzer LT, Janssen A, Roush N, Campbell JE, Su TZ, Hurst SI, Stoner CL, Schwarz JB.

Bioorg Med Chem Lett. 2009 May 1;19(9):2409-12. doi: 10.1016/j.bmcl.2009.03.077. Epub 2009 Mar 25.

PMID:
19346128
13.

AAPL Practice Guideline for the Forensic Evaluation of Psychiatric Disability.

Gold LH, Anfang SA, Drukteinis AM, Metzner JL, Price M, Wall BW, Wylonis L, Zonana HV.

J Am Acad Psychiatry Law. 2008;36(4 Suppl):S3-S50. No abstract available.

PMID:
19092058
14.

Without thinking: impulsive aggression and criminal responsibility.

Shuman DW, Gold LH.

Behav Sci Law. 2008;26(6):723-34. doi: 10.1002/bsl.847.

PMID:
19039791
15.

Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice.

Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, Koob GF, Tonegawa S, Zhang J, Xu M.

J Neurosci. 2007 Nov 28;27(48):13140-50.

16.

Do you understand your risk? Liability and third-party evaluations in civil litigation.

Gold LH, Davidson JE.

J Am Acad Psychiatry Law. 2007;35(2):200-10.

PMID:
17592166
17.

Psychiatric employment evaluations and theHealth Insurance Portability and Accountability Act.

Gold LH, Metzner JL.

Am J Psychiatry. 2006 Nov;163(11):1878-82. Review.

PMID:
17074937
18.

Formal training in women's issues in psychiatry: a survey of psychiatry residency training directors.

Gold LH, Epstein SA.

Acad Psychiatry. 2006 Sep-Oct;30(5):403-9.

PMID:
17021149
19.

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.

Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN.

J Med Chem. 2006 Jul 13;49(14):4425-36.

PMID:
16821801
20.

Robert I. Simon, MD: Of psychiatry, law, and books.

Gold LH, Gutheil TG.

J Am Acad Psychiatry Law. 2006;34(1):9-13. No abstract available.

PMID:
16696171
21.

Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia.

Floresco SB, Geyer MA, Gold LH, Grace AA.

Schizophr Bull. 2005 Oct;31(4):888-94. Epub 2005 Aug 3.

PMID:
16079387
22.

American Psychiatric Association honors Dorothea Dix with first posthumous fellowship.

Gold LH.

Psychiatr Serv. 2005 Apr;56(4):502. No abstract available.

PMID:
15875335
23.

AAPL and the death penalty: a historical perspective on the debate.

Gold LH.

J Am Acad Psychiatry Law. 2005;33(1):6-7. No abstract available.

PMID:
15809233
24.

Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.

Nielsen DM, Carey GJ, Gold LH.

Eur J Pharmacol. 2004 Sep 19;499(1-2):135-46.

PMID:
15363960
25.

Increased seizure threshold and severity in young transgenic CRND8 mice.

Del Vecchio RA, Gold LH, Novick SJ, Wong G, Hyde LA.

Neurosci Lett. 2004 Sep 2;367(2):164-7.

PMID:
15331144
26.
27.

Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection.

Weed MR, Gold LH, Polis I, Koob GF, Fox HS, Taffe MA.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):77-89.

PMID:
15000701
28.

MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys.

Taffe MA, HuitrĂ³n-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH.

Pharmacol Biochem Behav. 2003 Aug;76(1):141-52.

PMID:
13679227
29.

Incorporating the assessment of abuse liability into the drug discovery and development process.

Mansbach RS, Feltner DE, Gold LH, Schnoll SH.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S73-85. Review.

PMID:
12759198
30.

Psychopharmacologic treatment of depression during pregnancy.

Gold LH.

Curr Womens Health Rep. 2003 Jun;3(3):236-41. Review.

PMID:
12734035
31.

Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.

Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH.

Neuropsychopharmacology. 2002 Dec;27(6):993-1005.

32.

Introduction: transgenics and knockouts with mutations in genes for neuropeptides and their receptors.

Gold LH, Crawley JN.

Neuropeptides. 2002 Apr-Jun;36(2-3):61. No abstract available.

PMID:
12398063
33.

Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior.

Contarino A, Gold LH.

Neuropeptides. 2002 Apr-Jun;36(2-3):103-16. Review.

PMID:
12359502
34.

Ketamine impairs multiple cognitive domains in rhesus monkeys.

Taffe MA, Davis SA, Gutierrez T, Gold LH.

Drug Alcohol Depend. 2002 Oct 1;68(2):175-87.

35.

Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.

Contarino A, Picetti R, Matthes HW, Koob GF, Kieffer BL, Gold LH.

Eur J Pharmacol. 2002 Jun 20;446(1-3):103-9.

PMID:
12098591
36.

Automated assessment of conditioning parameters for context and cued fear in mice.

Contarino A, Baca L, Kennelly A, Gold LH.

Learn Mem. 2002 Mar-Apr;9(2):89-96.

37.

Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.

Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH.

Psychopharmacology (Berl). 2002 Mar;160(3):253-62. Epub 2002 Jan 22.

38.

Postpartum disorders in primary care: diagnosis and treatment.

Gold LH.

Prim Care. 2002 Mar;29(1):27-41, vi. Review.

PMID:
11856657
39.

Clinical and forensic aspects of postpartum disorders.

Gold LH.

J Am Acad Psychiatry Law. 2001;29(3):344-7. No abstract available.

PMID:
11592465
40.

Increased ethanol self-administration in delta-opioid receptor knockout mice.

Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL, Koob GF.

Alcohol Clin Exp Res. 2001 Sep;25(9):1249-56.

PMID:
11584142
41.

Paradigms for behavioral assessment of viral pathogenesis.

Weed MR, Gold LH.

Adv Virus Res. 2001;56:583-626. Review. No abstract available.

PMID:
11450313
42.
43.

Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.

David V, Gold LH, Koob GF, Cazala P.

Neuropsychopharmacology. 2001 Mar;24(3):300-18.

44.

Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

Taffe MA, Weed MR, Davis S, HuitrĂ³n-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH.

Neuropsychopharmacology. 2001 Mar;24(3):230-9.

45.

Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice.

Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW, Gold LH.

Endocrinology. 2000 Jul;141(7):2698-702.

PMID:
10875276
46.

mu-Opioid receptor knockout mice do not self-administer alcohol.

Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF, Gold LH.

J Pharmacol Exp Ther. 2000 Jun;293(3):1002-8.

47.

Treatment of depression during pregnancy.

Gold LH.

J Womens Health Gend Based Med. 1999 Jun;8(5):601-7. Review.

PMID:
10839645
48.

DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task.

Heyser CJ, Fienberg AA, Greengard P, Gold LH.

Brain Res. 2000 Jun 9;867(1-2):122-30.

PMID:
10837805
49.

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF.

Nat Genet. 2000 Apr;24(4):410-4.

PMID:
10742108
50.

Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice.

Dellu F, Contarino A, Simon H, Koob GF, Gold LH.

Neurobiol Learn Mem. 2000 Jan;73(1):31-48.

PMID:
10686122

Supplemental Content

Support Center